Identification, management and referral of adults with chronic kidney disease: concise guidelines.
about
Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic reviewThe need for improved identification and accurate classification of stages 3-5 Chronic Kidney Disease in primary care: retrospective cohort studyScreening for chronic kidney disease of uncertain aetiology in Sri Lanka: usability of surrogate biomarkers over dipstick proteinuriaCanadian chronic kidney disease clinics: a national survey of structure, function and models of care.Are pre-existing markers of chronic kidney disease associated with short-term mortality following acute community-acquired pneumonia and sepsis? A cohort study among older people with diabetes using electronic health recordsEarly Requirement for RRT in Children at Presentation in the United Kingdom: Association with Transplantation and Survival.Extreme sensitivity and the practical implications of risk assessment thresholds.Engaging primary care in CKD initiatives: the UK experience.Five-year follow-up after live donor nephrectomy - cross-sectional and longitudinal analysis of a prospective cohort within the era of extended donor eligibility criteria.Proteinuria in chronic renal disease was not mentioned.Is maternal renal disease a cause of elevated free beta-hCG in first trimester aneuploidy screening?The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population-based study.Albuminuria, proteinuria, and urinary albumin to protein ratio in chronic kidney disease.Severity of acute kidney injury and two-year outcomes in critically ill patients.Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan.
P2860
Q27000437-EC35A8EA-B52A-4096-B0D7-80558461EB81Q28541795-DD909A51-6F3C-43FB-A4E8-FDFDD7D87FFCQ33814769-09CB7E88-B4B0-431A-9405-7728F61C334DQ35147321-5F8DCD9C-E424-4897-AE85-F1B04C7E41DFQ35627694-24D2FAC7-4291-4CD4-8ACE-3E5ECA8755F7Q36874543-A47CC8E7-9DB9-4FF9-BC45-47D80CE5CC24Q36927916-F91F5CF9-E752-4AA6-8869-B52C033C9816Q38056885-8C313803-D458-40FF-8A1A-0F84C63CFBF4Q39311637-80BF1C71-2D21-4BD6-8CB6-4F7F928533B8Q43225544-D64C9093-68E2-48F8-884C-431502B9F859Q43294229-9DEE7147-E72A-4EC7-A3F2-69966E8FD60EQ43777165-94720045-04FC-4D1A-AA41-324C122068C9Q44706005-648A8F5E-04B5-4318-9E47-C369A5BA157CQ48007776-5E5077CF-1A07-485F-BD01-21ACE1FC7647Q54350404-8236F36A-0EB6-4E52-B205-43DF7D1AE4A1
P2860
Identification, management and referral of adults with chronic kidney disease: concise guidelines.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Identification, management and ...... y disease: concise guidelines.
@ast
Identification, management and ...... y disease: concise guidelines.
@en
Identification, management and ...... y disease: concise guidelines.
@nl
type
label
Identification, management and ...... y disease: concise guidelines.
@ast
Identification, management and ...... y disease: concise guidelines.
@en
Identification, management and ...... y disease: concise guidelines.
@nl
prefLabel
Identification, management and ...... y disease: concise guidelines.
@ast
Identification, management and ...... y disease: concise guidelines.
@en
Identification, management and ...... y disease: concise guidelines.
@nl
P1433
P1476
Identification, management and ...... y disease: concise guidelines.
@en
P2093
Guideline Development Committe ...... ndon and the Renal Association
Richard Burden
P304
P356
10.7861/CLINMEDICINE.5-6-635
P577
2005-11-01T00:00:00Z